Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Over 29 days of treatment, the peptide inhibited pulmonary artery muscularization (the thickening and stiffening of pulmonary arteries that drives this condition), prevented right heart hypertrophy (the enlargement of the right ventricle that occurs when it has to pump against increased resistance), and significantly decreased mortality
Batch-specific Certificates of Analysis (CoAs) are provided to support analytical verification, laboratory traceability, and research documentation standards
24(18):19721989 BPC 157 and standard angiogenic growth factors: gastrointestinal tract healing and lessons from musculoskeletal tissue models Disclaimer: This product is intended for laboratory research use only (RUO)
Follow structured rehabilitation
Ethical Concerns and Unregulated Use Despite the absence of regulatory approval, some compounding pharmacies and medical practitioners continue to promote and prescribe BPC-157
Important Context While the preclinical data is extensive and promising, it is essential to note that BPC-157 has not been evaluated in large-scale, randomized controlled human trials
US$ 20.85
US$ 28.27
US$ 26.58
US$ 27.83
US$ 22.45
US$ 28.14
US$ 26.87
US$ 24.46